Riess, Olaf http://orcid.org/0000-0002-7011-1369
Sturm, Marc http://orcid.org/0000-0002-6552-8362
Menden, Benita
Liebmann, Alexandra
Demidov, German http://orcid.org/0000-0001-9075-4276
Witt, Dennis http://orcid.org/0000-0001-8485-4860
Casadei, Nicolas http://orcid.org/0000-0003-2209-0580
Admard, Jakob http://orcid.org/0000-0003-0466-582X
Schütz, Leon http://orcid.org/0000-0001-7907-4878
Ossowski, Stephan
Taylor, Stacie http://orcid.org/0000-0001-6843-3505
Schaffer, Sven
Schroeder, Christopher
Dufke, Andreas http://orcid.org/0000-0002-5616-5010
Haack, Tobias
Article History
Received: 1 September 2023
Accepted: 7 February 2024
First Online: 14 March 2024
Competing interests
: S.T. and S.S. declare to be employees and shareholders of Illumina, Inc. S.O. received travel support and speaker fees from Illumina, Inc. and Oxford Nanopore Technologies, Inc. O.R., T.H., S.O., and C.S. report institutional grants from Illumina, and C.S. has received research grants from BMS Stiftung Immunonkologie and Westdeutsche Studiengruppe GmbH outside the submitted work. All other authors declare no competing interests.